Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Deferred Taxes: 2023-2024

Historic Deferred Taxes for Theravance Biopharma (TBPH) over the last 2 years, with Dec 2024 value amounting to -$7.6 million.

  • Theravance Biopharma's Deferred Taxes rose 1004.44% to $994,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.1 million, marking a year-over-year change of. This contributed to the annual value of -$7.6 million for FY2024, which is 336.14% down from last year.
  • As of FY2024, Theravance Biopharma's Deferred Taxes stood at -$7.6 million, which was down 336.14% from $3.2 million recorded in FY2023.
  • Over the past 5 years, Theravance Biopharma's Deferred Taxes peaked at $3.2 million during FY2023, and registered a low of -$7.6 million during FY2024.
  • Over the past 2 years, Theravance Biopharma's median Deferred Taxes value was -$2.2 million (recorded in 2023), while the average stood at -$2.2 million.
  • Data for Theravance Biopharma's Deferred Taxes shows a maximum YoY slumped of 336.14% (in 2024) over the last 5 years.
  • Theravance Biopharma's Deferred Taxes (Yearly) stood at $3.2 million in 2023, then plummeted by 336.14% to -$7.6 million in 2024.